CardioFocus Competitors and Similar CompaniesClear all
CardioFocus's competitors and similar companies include Endothelix, ProcessHQ, Eyenovia and XVIVO Perfusion.
 Endothelix Endothelix is a cardiovascular device company focused on non-invasive vascular function measurement. |  Eyenovia Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform. |  XVIVO Perfusion XVIVO Perfusion is a medical technology company that develops machines and perfusion solutions. | |||
Founding Date | Founding Date 1990 | Founding Date 2003 | Founding Date 1999 | Founding Date 2014 | Founding Date 1998 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Marlborough, US HQ | Locations Houston, US HQ Palo Alto, US | Locations Burbank, US HQ Los Angeles, US | Locations New York, US HQ | Locations Mölndal, SE HQ Shanghai, CN Novegro Tregarezzo, IT Groningen, NL Lund, SE Mölndal, SE Aurora, US see more |
Employees | Employees 70 | Employees 7 | Employees 7 | Employees 22100% increase | Employees 19320% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 47.3 m | Valuation ($) 1.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $813.5k (FY, 2025) | Revenue (est.) kr812.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $303.3k (FY, 2025) | Cost of goods kr208.5m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $510.2k (FY, 2025) | Gross profit kr605.4m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($45.3m) (FY, 2025) | Net income kr25.2m (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 55m (almost 7 years ago) | Latest funding round $ 500k (almost 20 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 186.6m | Total funding raised $ 500k | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Endothelix
HQ
Houston, US
Employees
7
Endothelix is a cardiovascular device company focused on non-invasive vascular function measurement.
View company
ProcessHQ
HQ
Burbank, US
Employees
7
ProcessHQ is an integrated Bioprocess solutions provider.
View companyEyenovia
HQ
New York, US
Employees
22
Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform.
View companyXVIVO Perfusion
HQ
Mölndal, SE
Employees
193↑ 20% increase
XVIVO Perfusion is a medical technology company that develops machines and perfusion solutions.
View company